Molecular analysis and anticonvulsant therapy in two patients with glucose transporter 1 deficiency syndrome: A successful use of zonisamide for controlling the seizures

Epilepsy Research

Volumn 80, Issue 1, 2008, Pages 18-22

  Takahashi, Satoru ^a   Ohinata, Junko ^a   Suzuki, Nao ^a   Amamiya, Satoshi ^a   Kajihama, Aya ^b   Sugai, Rika ^b   Araki, Akiko ^a   Fujieda, Kenji ^a   Tanaka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Monbetsu Hospital   (Japan)

Author keywords

Glucose transporter 1; Ketogenic diet; Mutation; Seizure; Zonisamide

Indexed keywords

BARBITURIC ACID DERIVATIVE; CHLORAL HYDRATE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; GLUCOSE TRANSPORTER 1; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; ZONISAMIDE;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; SCHOOL CHILD; SEIZURE; TREATMENT RESPONSE;

ANTICONVULSANTS; BIOLOGICAL TRANSPORT; CHILD; DNA MUTATIONAL ANALYSIS; ERYTHROCYTES; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; ISOXAZOLES; MALE; METHYLGALACTOSIDES; SEIZURES;

EID: 44749085375     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.03.010     Document Type: Article

References (21)

1. De Vivo D.C., Trifiletti R.R., Jacobson R.I., Ronen G.M., Behmand R.A., and Harik S.I. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N. Engl. J. Med. 325 (1991) 703-709
2. Farrell C.L., and Pardridge W.M. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5779-5783
3. Fujii T., Ho Y.Y., Wang D., De Vivo D.C., Miyajima T., Wong H.Y., Tsang P.T., Shirasaka Y., Kudo T., and Ito M. Three Japanese patients with glucose transporter type 1 deficiency syndrome. Brain Dev. 29 (2007) 92-97
4. Ho Y.Y., Yang H., Klepper J., Fischbarg J., Wang D., and De Vivo D.C. Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro. Pediatr. Res. 50 (2001) 254-260
5. Honkanen R.A., McBath H., Kushmerick C., Callender G.E., Scarlata S.F., Fenstermacher J.D., and Haspel H.C. Barbiturates inhibit hexose transport in cultured mammalian cells and human erythrocytes and interact directly with purified GLUT-1. Biochemistry 34 (1995) 535-544
6. Klepper J., Fischbarg J., Vera J.C., Wang D., and De Vivo D.C. GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro. Pediatr. Res. 46 (1999) 677-683
7. Klepper J., Garcia-Alvarez M., O'Driscoll K.R., Parides M.K., Wang D., Ho Y.Y., and De Vivo D.C. Erythrocyte 3-O-methyl-d-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome. J. Clin. Lab. Anal. 13 (1999) 116-121
8. Klepper J., Wang D., Fischbarg J., Vera J.C., Jarjour I.T., O'Driscoll K.R., and De Vivo D.C. Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome. Neurochem. Res. 24 (1999) 587-594
9. Klepper J., Willemsen M., Verrips A., Guertsen E., Herrmann R., Kutzick C., Florcken A., and Voit T. Autosomal dominant transmission of GLUT1 deficiency. Hum. Mol. Genet. 10 (2001) 63-68
10. Klepper J., and Voit T. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain-a review. Eur. J. Pediatr. 161 (2002) 295-304
11. Klepper J., Florcken A., Fischbarg J., and Voit T. Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro. Eur. J. Pediatr. 162 (2003) 84-89
12. Leary L.D., Wang D., Nordli Jr. D.R., Engelstad K., and De Vivo D.C. Seizure characterization and electroencephalographic features in GLUT-1 deficiency syndrome. Epilepsia 44 (2003) 701-707
13. Mueckler M., Caruso C., Baldwin S.A., Panico M., Blench I., Morris H.R., Allard W.J., and Lienhard G.E. Sequence and structure of a human glucose transporter. Science 229 (1985) 941-945
14. Nordli Jr. D.R., and De Vivo D.C. The ketogenic diet revisited: back to the future. Epilepsia 38 (1997) 743-749
15. Ohtahara S. Zonisamide in the management of epilepsy-Japanese experience. Epilepsy Res. Suppl. 2 (2006) S25-S33
16. Pardridge W.M., Boado R.J., and Farrell C.R. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier Studies with quantitative western blotting and in situ hybridisation. J. Biol. Chem. 265 (1990) 18035-18040
17. Seidner G., Alvarez M.G., Yeh J.I., O'Driscoll K.R., Klepper J., Stump T.S., Wang D., Spinner N.B., Birnbaum M.J., and De Vivo D.C. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat. Genet. 18 (1998) 188-191
18. Tao T., Tanizawa Y., Matsutani A., Matsubara A., Kaneko T., and Kaku K. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a association study and molecular scanning in Japanese subjects. Diabetologia 38 (1995) 942-947
19. Wang D., Kranz-Eble P., and De Vivo D.C. Mutational analysis of GLUT1 (SLC2A1) in GLUT-1 deficiency syndrome. Hum. Mutat. 16 (2000) 224-231
20. Wang D., Pascual J.M., Yang H., Engelstad K., Jhung S., Sun R.P., and De Vivo D.C. GLUT-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann. Neurol. 57 (2005) 111-118
21. Wong H.Y., Chu T.S., Lai J.C., Fung K.P., Fok T.F., Fujii T., and Ho Y.Y. Sodium valproate inhibits glucose transport and exacerbates GLUT1-deficiency in vitro. J. Cell Biochem. 96 (2005) 775-785